• LAST PRICE
    1.2500
  • TODAY'S CHANGE (%)
    Trending Down-0.0500 (-3.8462%)
  • Bid / Lots
    1.3500/ 10
  • Ask / Lots
    1.9500/ 9
  • Open / Previous Close
    1.2600 / 1.3000
  • Day Range
    Low 1.2500
    High 1.3391
  • 52 Week Range
    Low 1.2500
    High 8.1000
  • Volume
    7,027
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.3
TimeVolumeFEMY
09:32 ET1081.26
09:41 ET10001.3391
09:48 ET23291.3
10:15 ET1001.3
10:24 ET1001.2937
11:22 ET1001.3
11:49 ET3001.3
02:06 ET5001.28
03:23 ET2021.3
03:59 ET3081.25
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFEMY
Femasys Inc
14.8M
-1.5x
---
United StatesNAOV
Nanovibronix Inc
15.1M
-1.2x
---
United StatesWHSI
Wearable Health Solutions Inc
16.9M
0.0x
---
United StatesRNXT
RenovoRx Inc
16.6M
-1.4x
---
United StatesBJDX
Bluejay Diagnostics Inc
16.8M
-2.5x
---
United StatesPBIO
Pressure Biosciences Inc
12.0M
-0.6x
---
As of 2022-09-25

Company Information

Femasys Inc. is a biomedical company. The Company is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.

Contact Information

Headquarters
3950 JOHNS CREEK COURT, SUITE 100SUWANEE, GA, United States 30024
Phone
770-500-3910
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Charles Larsen
President, Chief Executive Officer, Director
Kathy Lee-Sepsick
Chief Financial Officer
Dov Elefant
Senior Vice President - Operations
Daniel Currie
Vice President of Finance and Administration
Gary Thompson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$14.8M
Revenue (TTM)
$1.1M
Shares Outstanding
11.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.86
Book Value
$2.23
P/E Ratio
-1.5x
Price/Sales (TTM)
12.9
Price/Cash Flow (TTM)
---
Operating Margin
-883.98%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.